Masimo Corp MASI
News
Masimo Receives FDA Clearance for Stork™ Over-the-Counter (OTC) Baby Monitoring System
Masimo to Report First Quarter 2024 Financial Results after Market Close on Tuesday, May 7
Masimo Founder and CEO Joe Kiani to Speak on AI at Global Patient Safety Summit in Chile
Masimo Responds to Politan Capital’s Nomination of Director Candidates and Refutes Politan’s False Claims
Masimo's stock gains on report of activist campaign, disclosure of spinoff plan
Politan Nominates Two Independent Candidates for Masimo Board
Masimo Corporation Board of Directors Authorizes Management to Evaluate the Separation of Consumer Business
MASIMO ALERT: Bragar Eagel & Squire, P.C. is Investigating Masimo Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Masimo Named One of Fast Company’s Most Innovative Companies in North America
Masimo Celebrates Multiple Wins at the iF DESIGN AWARDS 2024
Masimo to Present in 45th Annual Raymond James Institutional Investors Conference
Masimo Reports Fourth Quarter and Full-Year 2023 Financial Results
Masimo and UCHealth Announce a Clinical Monitoring Partnership to Improve Care with Telehealth
Masimo Announces the First FDA-cleared “Over-the-Counter” Fingertip Pulse Oximeter
New Peer-Reviewed Study Finds That Masimo SET® Pulse Oximetry Measures Accurately on Both Black and White People Even During Low Perfusion
Apple Barred From Selling Watches With Blood-Oxygen Sensors in U.S., CNBC Reports
Apple Watch interruption could fuel a revenue decline in the important December quarter
Apple Watch interruption could fuel a revenue decline in the important December quarter
Some Apple Watch sales will be halted starting Thursday; stock falls